| scholarly article | Q13442814 |
| P50 | author | Tore K. Kvien | Q65660760 |
| P2093 | author name string | Manger B | |
| Førre O | |||
| Hannonen P | |||
| Leirisalo-Repo M | |||
| Wollheim FA | |||
| Kurki P | |||
| Prestele H | |||
| Laasonen L | |||
| Kaltwasser JP | |||
| Hafström I | |||
| Zeidler HK | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study | Q28377387 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis. | Q33638269 | ||
| The role of current strategies in the future treatment of rheumatoid arthritis | Q33823976 | ||
| The links between joint damage and disability in rheumatoid arthritis | Q33867923 | ||
| Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study | Q35547691 | ||
| Cyclosporine in rheumatoid arthritis: documented efficacy and safety | Q35693291 | ||
| Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. | Q36858099 | ||
| Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis? | Q40158596 | ||
| DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage | Q40555281 | ||
| DC-ART classification: review of relevant clinical studies | Q40555287 | ||
| The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review | Q40629157 | ||
| New perspectives on controlling progression of severe rheumatoid arthritis--a summary of the potential role of cyclosporin | Q41114436 | ||
| Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry | Q41116423 | ||
| The Assessment of Disability: from first to future principles | Q41443415 | ||
| The use of cyclosporin A microemulsion in rheumatoid arthritis: conclusions of an international review | Q41560772 | ||
| Disease-modifying anti-rheumatic drugs. Cyclosporin | Q41648291 | ||
| Renal biopsy findings in long-term cyclosporin treatment of psoriasis | Q42656423 | ||
| Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. | Q50987548 | ||
| Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy. | Q51005080 | ||
| Smallest detectable difference in radiological progression. | Q52909883 | ||
| Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone | Q56420815 | ||
| Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis | Q57169679 | ||
| Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin a | Q57753964 | ||
| Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis | Q67731566 | ||
| Early rheumatoid arthritis--onset, course, and outcome over 2 years | Q68634122 | ||
| Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease | Q69667742 | ||
| Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study | Q71022576 | ||
| Cyclosporine in rheumatoid arthritis | Q71052496 | ||
| Rheumatoid arthritis: treat now, not later! | Q71086317 | ||
| Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study | Q71603077 | ||
| Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis | Q72314578 | ||
| The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study | Q72314582 | ||
| Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group | Q72767547 | ||
| Renal biopsy specimens from patients with rheumatoid arthritis and apparently normal renal function after therapy with cyclosporine. Canadian Multicentre Rheumatology Group | Q72780109 | ||
| Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate | Q73252607 | ||
| Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores | Q73490991 | ||
| Neoral--new cyclosporin for old? | Q73891154 | ||
| The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up | Q74046797 | ||
| Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold | Q77291739 | ||
| Renal toxicity of long-term cyclosporin | Q77402621 | ||
| Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate | Q77674605 | ||
| Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss | Q77745475 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 511-516 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension | |
| P478 | volume | 61 |
| Q36407314 | Basic immunosuppressive drugs outside solid organ transplantation |
| Q51329120 | Effect of tumor necrosis factor-α inhibitors on ambulatory 24-h blood pressure. |
| Q37158219 | Hypertension in rheumatoid arthritis. |
| Q35553834 | Infliximab in active early rheumatoid arthritis |
| Q46598130 | Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients |
| Q50714401 | Lip hypertrophy secondary to cyclosporine treatment: a rare adverse effect and treatment considerations. |
| Q30437479 | Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q38289964 | Pediatric spinal trauma |
| Q38925320 | The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review |
| Q37640953 | The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review |
Search more.